CD226 and neuroblastoma: While this suggests DNAM-1+ NK cells may have broader application due to the potent effector function shown regardless of whether or not the tumor target expresses CD155 or CD112, neuroblastoma cells that express CD155 display the highest susceptibility to NK-mediated killing [40].